Back to Journals » Patient Preference and Adherence » Call For Papers

Patient Preference and Adherence

ISSN: 1177-889X

The following Article Collections/ Thematic Series are currently open for submissions:

Advancing Medical Problem-Oriented Approaches in Infectious Disease Management

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection entitled “Advancing Medical Problem-Oriented Approaches in Infectious Disease Management”, organized by Dr. Ahmad Riyad Alsayed, in Patient Preference and Adherence.

Infectious diseases remain a significant global health challenge, with the emergence of new pathogens, the spread of drug-resistant strains, and the ongoing threat of pandemics. In response to these challenges, infectious disease management has continuously evolved, adopting innovative strategies to combat common and emerging infections. This Collection aims to highlight and disseminate cutting-edge research and developments in the field, particularly on problem-oriented approaches.

Scope and Objectives

This Article Collection seeks to provide a comprehensive platform for researchers, clinicians, and public health experts to share their insights and findings related to problem-oriented approaches in infectious disease management. The primary objectives of this Article Collection include:

1. Illuminating the critical issues surrounding drugs and treatment, using classification systems like drug-related problems (DRPs), treatment-related problems, or recently, the medical problems-oriented plan (MPOP), with the ultimate goal of enhancing patient outcomes and the overall quality of care in patients suffering from infectious diseases.
2. Exploring Novel Diagnostic Tools: Papers in this Article Collection will delve into the development and application of innovative diagnostic tools, including molecular techniques, point-of-care devices, and artificial intelligence-driven algorithms, to enhance the rapid and accurate detection of infectious pathogens, considering patient acceptance and adherence.
3. Advancements in Therapeutic Strategies: Researchers are encouraged to present studies on discovering and evaluating new therapeutic agents, vaccines, and treatment modalities for infectious diseases. Emphasis should be placed on personalized and precision medicine approaches.
4. Surveillance and Epidemiological Studies: Contributions that focus on using epidemiological models, big data analytics, and advanced surveillance systems to predict, prevent, and manage infectious disease outbreaks will be featured.
5. Antimicrobial Stewardship: Papers discussing the implementation of antimicrobial stewardship programs in healthcare settings and strategies to combat antimicrobial resistance will be considered for inclusion.

The deadline for submissions is 31 December 2024. Please review the journal’s aims and scope, alongside the author submission instructions prior to completing your submission.

Please submit your manuscript on our website, quoting the promo code EHHUY to indicate that your submission is for consideration in this Article Collection.

Guest advisor

Ahmad Riyad Alsayed, Applied Science Private University

[email protected]

The main aims of Dr. Alsayed's practice and research are to promote evidence-based medication use to improve disease outcome and health-related quality of life of patients with internal medicine-related disorders. His current research interests include clinical pharmacy, evidence-based medicine, clinical trials of effectiveness and safety, quality of life, and pharmaceutical care,  with a special interest in infectious, respiratory, diabetes, and cardiovascular diseases.​

View all papers in this article collection

 Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence

Dove Medical Press is pleased to invite you to submit your research to an upcoming Article Collection on "Enhancing Medication Safety: Prioritizing Risk Management and Ensuring Safe Dispensing, Prescribing, Pharmacovigilance, and Patient Adherence", organized by Guest Advisors Dr. Mansour Adam Mahmoud and Dr. Alnada Ibrahim in Patient Preference and Adherence

Safe medication use is of paramount importance in healthcare systems. The quality of healthcare depends on the safety of medication use, that will ultimately lead to patient safety. Medication safety involves safe medication use during dispensing, prescribing, monitoring and administering medication to the patients. Any disruption occurring in these pivotal stages has the potential for patient harm. At the forefront of these efforts, pharmacovigilance emerges as a proactive process, fostering vigilance among healthcare professionals, patients, and caregivers alike. Through appropriate adverse drug reaction reporting systems, pharmacovigilance ensures the reporting of critical information to relevant regulatory bodies. These bodies subsequently utilize the aggregated data to derive meaningful conclusions and make informed decisions regarding the safety profiles of specific medications. In addition, adherence to prescribed medications assumes paramount significance. Despite their importance, numerous studies underscore the tendency of patients to deviate from their prescribed medication regimens. Effectively measuring adherence mandates the application of validated tools tailored for this purpose. In this domain, an array of methodically validated tools exists, designed to accurately measure and evaluate medication adherence. 

Adhering to established medication safety protocols and guidelines is of utmost significance to mitigate patient harm and enhance overall patient safety. Prominent organizations including the World Health Organization (WHO), the Institute of Safe Medication Practice (ISM), the International Pharmaceutical Federation (FIP) among others, have issued vital recommendations aimed at strengthening patient safety and enhancing medication safety. Incorporating these guidelines alongside tailored quality assurance systems within hospitals, community healthcare centers, and relevant institutions holds the potential to reduce medication errors, adverse drug events, and reactions. 

We invite scholars, researchers, and practitioners to contribute to our upcoming Article Collection focused on the critical area of safe medication usage. The Collection aims to explore various facets, including pharmacovigilance, medication safety, safe prescribing including pharmacist prescribing, and dispensing practices, ensuring the well-being of the public. 

All manuscripts submitted to this Article Collection will undergo desk assessment and peer-review as part of our standard editorial process. Guest Advisors for this collection will not be involved in peer-reviewing manuscripts unless they are an existing member of the Editorial Board. Please review the journal Aims and Scope and author submission instructions prior to submitting a manuscript. 


  • Medication Safety
  • Safe dispensing and Prescribing
  • Pharmacovigilance
  • Adherence
  • Patient Safety

The deadline for submissions is 30 September 2024. Please review the journal’s Aims and Scope, alongside the author submission instructions prior to completing your submission.

Please submit your manuscript on our website, quoting the promo code BCDLN to indicate that your submission is for consideration in this Article Collection.

Guest advisors

Mansour Adam Mahmoud, Department of Clinical and Hospital Pharmacy, Taibah University

[email protected]

Dr. Mansour Adam Mahmoud is currently working as an associate professor at the Department of Clinical and Hospital Pharmacy, College of Pharmacy, Taibah University. He has more than 12 years of experience in teaching, learning and research. His areas of research interest are medication safety and pharmacovigilance, clinical pharmacy practice, pharmacy education and global health. Mansour has authored and co-authored more than 100 scientific articles published in international peer-reviewed journals. He has also authored and co-authored two book chapters and one e-book. His current Google Scholar H-index is 20, i-10 31, citations more than 1500. Mansour has actively participated in the WHO Global Patient Safety Challenge: Medication without Harm which was launched in 2017 aiming to reduce medication-related harm by 50%. Dr. Mansour has taken up roles as an associate editor and spearheaded various research topics in the realm of Medication Safety, Interventions to Mitigate Patient Harm, Vaccines Safety During Emerging Infections, and the Concerns of Special Populations and Minority Groups. Recognizing his accomplishments, international organizations have honored Dr. Mahmoud with travel awards, enabling him to share his research findings in Canada, Taiwan, and the UK.

Alnada Ibrahim, College of Pharmacy, Princess Nourah bint Abdulrahman University

[email protected]

Dr. Alnada Ibrahim, PhD in Pharmacy Practice, graduated from the University of Bath, United Kingdom. She is currently working as Associate Professor at the Department of Pharmacy Practice, College of Pharmacy, Princess Nourah bint Abdurrahman University, Saudi Arabia. Her research interests lie in the area of medication safety, pharmaceutical care, assessing pharmacists' roles in a variety of capacities, clinical pharmacokinetics, and pharmacy education. She published around 25 papers in international peer-reviewed journals. She also presented various academic topics as well as research-based papers at several national and international conferences. Currently, she is working with some multidisciplinary research groups that conduct and share research across a range of issues.



View all papers in this article collection

Call For Papers

Editor-in-Chief: Dr Johnny Chen

To see where Patient Preference and Adherence is indexed online view the Journal Metrics

What is the advantage to you of publishing in Patient Preference and Adherence?

  • It is an open access journal which means that your paper is available to anyone in the world to download for free directly from the Dove website.
  • Although Patient Preference and Adherence receives a large number of papers, unlike many traditional journals, your paper will not be rejected due to lack of space. We are an electronic journal and there are no limits on the number or size of the papers we can publish.
  • The time from submission to a decision being made on a paper can, in many journals, take some months and this is very frustrating for authors. Patient Preference and Adherence has a quicker turnaround time than this. Generally peer review is complete within 3-4 weeks and the editor’s decision within 2-14 days of this. It is therefore very rare to have to wait more than 6 weeks for first editorial decision.
  • Many authors have found that our peer reviewer’s comments substantially add to their final papers.

To recover our editorial and production costs and continue to provide our content at no cost to readers we charge authors or their institution an article publishing charge.

PubMed Central
Patient Preference and Adherence is indexed on PubMed and MedLine (title abbreviation: Patient Prefer Adherence). All published papers in this journal are submitted to PubMed for indexing straight away. 

Become a Favored Author and receive real benefits

If you haven't already joined the Dove Press Favored Author Program I would encourage you to do so. Why? To receive real benefits like fast-tracking and a personal co-ordinator for your paper, as well as a discount on the publication processing fee.
Click here to go through to the Favored Author signup page.

Yours sincerely
Dr Johnny Chen
Patient Preference and Adherence

Email: Editor-in-Chief